Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection.
Human metapneumovirus (hMPV) is an important cause of lower respiratory tract disease, particularly in infants and young children. hMPV has two major glycoproteins, G and F, which are responsible for virus attachment and membrane fusion, respectively. We investigated the role of cellular glycosaminoglycans (GAGs) and G protein in hMPV infection. The pretreatment of hMPV with soluble heparin markedly inhibited the infection of HEp-2 cells. Recombinant G protein, comprising the extracellular domain of G, bound to heparin-agarose columns and also to HEp-2 cells. hMPV infection and G protein binding to HEp-2 cells was inhibited by other soluble GAGs, including chondroitin sulfates, by the enzymatic removal of cell surface GAGs with GAG lyases or by the pretreatment of cells with basic fibroblast growth factor. The role of cellular GAGs was confirmed by the binding of G protein to wild-type CHO cells but not to GAG-deficient CHO-pgsA745 cells. An analysis of the G protein sequence revealed two adjacent clusters of positively charged amino acids ((149)EKKKTRA(155) and (159)QRRGKGKE(166)). Truncated G fragments were expressed, and only the fragment containing these putative heparin binding domains retained heparin binding. The alanine mutagenesis of charged residues in either of these regions resulted in the loss of binding to heparin and to HEp-2 cells, suggesting that both sites are likely to be required for hMPV attachment. These results, taken together with the inhibition of hMPV infection by soluble G protein, indicate an important role for G protein and cellular GAGs in hMPV infection.
Thammawat
Sutthiwan
S
Department of Microbiology and Infectious Diseases, Flinders Medical Centre, Bedford Park, SA 5042, Australia.
Sadlon
Tania A
TA
Hallsworth
Peter G
PG
Gordon
David L
DL
D000818:Animals; D016264:Dextran Sulfate / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000502:physiology*; D006493:Heparin / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007067:Iduronic Acid / Q000494:pharmacology; D008253:Macaca mulatta; D029121:Metapneumovirus; D018184:Paramyxoviridae Infections / Q000209:etiology*; D011485:Protein Binding; D014759:Viral Envelope Proteins / Q000502:physiology*
D006025:Glycosaminoglycans; D014759:Viral Envelope Proteins; C116204:attachment protein G; D007067:Iduronic Acid; D006493:Heparin; D016264:Dextran Sulfate
Arteriosclerosis. 1989 Jan-Feb;9(1):21-32
2463827
Biochimie. 2001 Aug;83(8):811-7
11530214
Eur J Immunol. 2003 Apr;33(4):962-9
12672062
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3546-50
7724595
Virology. 2002 Mar 30;295(1):119-32
12033771
Virology. 2002 Mar 15;294(2):296-304
12009871
Antimicrob Agents Chemother. 1991 Dec;35(12):2515-20
1725692
Clin Microbiol Rev. 2006 Jul;19(3):546-57
16847085
J Virol. 2005 Oct;79(19):12608-13
16160190
J Virol. 2002 Jun;76(12):6164-71
12021350
Antiviral Res. 2004 Jul;63(1):51-9
15196820
J Biol Chem. 1993 Sep 15;268(26):19228-31
8366075
J Virol. 2000 Jul;74(14):6442-7
10864656
J Virol. 2000 Nov;74(22):10508-13
11044095
J Virol. 2003 Mar;77(5):3269-80
12584350
J Virol. 2004 Dec;78(23):12877-87
15542640
Arch Virol. 2003 Oct;148(10):1987-2003
14551820
Arch Virol. 1997;142(6):1247-54
9229012
J Virol. 1998 Sep;72(9):7349-56
9696831
J Infect Dis. 2002 Jun 1;185(11):1660-3
12023774
Virology. 2003 Oct 10;315(1):1-9
14592754
J Gen Virol. 1996 Jun;77 ( Pt 6):1249-57
8683213
J Virol. 2001 Jul;75(14):6303-9
11413296
Biochemistry. 1990 Mar 13;29(10):2611-7
2334685
Virology. 2002 Jan 5;292(1):162-8
11878919
Virology. 2000 Jun 5;271(2):264-75
10860881
Methods Mol Biol. 2007;379:15-34
17502668
J Biol Chem. 1992 May 25;267(15):10337-41
1587820
J Gen Virol. 2004 Mar;85(Pt 3):679-686
14993653
J Virol. 2007 Dec;81(24):13435-43
17913798
Nat Med. 2001 Jun;7(6):719-24
11385510
Virology. 2001 Oct 25;289(2):283-96
11689051
Proc Natl Acad Sci U S A. 1985 May;82(10):3197-201
3858816
J Virol. 1998 Sep;72(9):7357-66
9696832
J Virol. 1999 Aug;73(8):6610-7
10400758
J Clin Microbiol. 2004 Aug;42(8):3532-7
15297494
Antimicrob Agents Chemother. 1988 Nov;32(11):1742-5
2472775